Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income - Minority (2016 - 2019)

Fortress Biotech has reported Net Income - Minority over the past 5 years, most recently at -$29.9 million for Q1 2019.

  • For Q1 2019, Net Income - Minority changed N/A year-over-year to -$29.9 million; the TTM value through Mar 2019 reached -$29.9 million, changed N/A, while the annual FY2018 figure was -$17.9 million, 73.66% up from the prior year.
  • Net Income - Minority for Q1 2019 was -$29.9 million at Fortress Biotech, down from -$17.9 million in the prior quarter.
  • Over five years, Net Income - Minority peaked at -$17.9 million in Q4 2018 and troughed at -$67.9 million in Q4 2017.
  • A 5-year average of -$41.0 million and a median of -$44.5 million in 2016 define the central range for Net Income - Minority.
  • Biggest five-year swings in Net Income - Minority: crashed 62.15% in 2016 and later soared 73.66% in 2018.
  • Year by year, Net Income - Minority stood at -$27.4 million in 2015, then plummeted by 62.15% to -$44.5 million in 2016, then tumbled by 52.74% to -$67.9 million in 2017, then soared by 73.66% to -$17.9 million in 2018, then tumbled by 67.08% to -$29.9 million in 2019.
  • Business Quant data shows Net Income - Minority for FBIO at -$29.9 million in Q1 2019, -$17.9 million in Q4 2018, and -$46.9 million in Q3 2018.